Drug Trial Radar · NCT05323734
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
Last checked: Nov 19, 2026Latest source record: Jul 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
129
Actual
Start
Apr 1, 2022
Primary completion
Sep 9, 2024
Study completion Oct 14, 2024
Sponsor
- Lead sponsor
- Marinus PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Apr 12, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, global, double-blind, randomized, placebo-controlled study of adjunctive GNX treatment in children and adults with TSC-related epilepsy. The study consists of a 4-week prospective Baseline phase, defined as the first 28 days following screening, followed by a double-blind phase consisting of a 4-week titration period (Day 1 to Day 28) and a 12-week maintenance period (Day 29 to Week 16).
Conditions
- Tuberous Sclerosis Complex
Interventions
GanaxoloneDrug
GNX will be administered
PlaceboDrug
Placebo will be administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in 28-day Seizure Frequency for Primary Seizure Type During Double Blind PeriodTime frame: Baseline (Day 1), Day 28
Locations
63 sites in 10 countries. Site status is shown where the registry gives one.
Arkansas Children's Research Institute
Little Rock, Arkansas
UCLA Mattel Children's Hospital, TSC Center
Los Angeles, California
Children's Hospital of Orange County
Orange, California
University of California, San Diego
San Diego, California
Childrens Hospital Colorado
Aurora, Colorado
Nemours Children's Hospital - Delaware Valley
Wilmington, Delaware
University of Florida Gainesville
Gainesville, Florida
Nemours Children's Health
Jacksonville, Florida
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland
Mayo Clinic - Rochester
Rochester, Minnesota
Children's Mercy Hosptial
Kansas City, Missouri
University of Rochester Medical Center
Rochester, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Atrium Health/Levine Children's Hospital
Charlotte, North Carolina
Duke University Medical Center
Durham, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Penn State Children's Hospital
Hershey, Pennsylvania
Le Bonheur Children's Hospital
Memphis, Tennessee
Child Neurology Consultants of Austin (CNCA)
Austin, Texas
University of Texas Southwestern Medical Center
Dallas, Texas
McGovern Medical School at the University of Texas Health Science Center
Houston, Texas
University of Utah Health Care-Pediatric Neurology
Salt Lake City, Utah
Seattle Children's Hospital
Seattle, Washington
Austin Health
Heidelberg, Australia
Alfred Health
Melbourne, Australia
Royal Melbourne Hospital
Parkville, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Hôtel Dieu de Montréal - CHUM
Montreal, Canada
CHU Sainte-Justine
Montreal, Canada
The Hospital for Sick Children
Toronto, Canada
Toronto Western Hospital
Toronto, Canada
BC Children's Hospital
Vancouver, Canada
Peking University First Hospital
Beijing, China
Chinese PLA General Hospital
Beijing, China
Chengdu's Women and Children's Central Hospital
Chengdu, China
First Hospital of Jilin University
Changchun, Jilin, China
Jiangxi Provincial Children's Hospital
Jiangxi, Nanchang City, China
Beijing Children Hospital, Capital Medical University
Beijing, Xicheng District, China
The Affiliated Hospital of Guizhou Medical University
Guiyang, Yunyan District, China
University Hospital of Lyon
Bron, France
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.